The coronavirus extended its grip across the world on Monday, hitting Brazil particularly hard as both the U.S. and China grappled with a surge of new cases that called into question the recent wave of gradually easing restrictions.
Separately, the Food and Drug Administration appeared to end a polarizing debate over hydroxychloroquine by yanking its emergency use designation. The drug was once touted as a potential “game changer” by President Donald Trump in the fight against COVID-19, but has since been linked to deadly side effects.
Overall, the virus has now affected nearly 8 million globally, with more than 433,000 reported dead. In the U.S., more than 2 million cases have been reported and more than 115,000 have died amid a case spike in over half a dozen states showing worrying multi-day trends of increases.
In China, where the virus first appeared, Beijing
reported a modest rise in cases tied to a food market, prompting the government to adopt a “wartime” posture. Meanwhile, Brazil has become an avatar of a
Latin American region that’s rapidly emerged as a global hotspot.
Though many public health officials maintain the surges in the U.S. are part of the first wave of the virus,
stocks and oil slid Monday on fears a second wave could hit sooner than the expected fall/winter timelines.
Public officials have noted concerns over states like Texas, Florida, Arizona and California — which has some of the most restrictive orders on the books yet has still seen COVID-19 diagnoses spike recently. The Golden State has now seen 5,000 deaths and nearly 150,000 cases,
according to state data.